Access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Ongoing seminars allow cancer specialists to share knowledge and foster new collaborations.
Education and professional development designed to train the next generation of cancer researchers and physicians.
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
Internal and external sources of support for both established cancer research programs and promising new ideas.
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Steven Artandi, Laura Attardi and Amato Giaccia will receive up to $600,000 annually for seven years to study cancer processes.
With the donated tissue, a Stanford team has created the first cell line and mouse model of diffuse intrinsic pontine glioma, a deadly tumor.